Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

The Malaria & Critical Illness Department has a vibrant and productive network of collaborative study sites throughout South-East Asia, South Asia and Africa, with around 15 studies currently operating in a total of an equal number of countries.

MORU Study sites

In 2018 the Malaria & Critical illness Department completed the large multi-centre multi-country TRAC II study. This study continued tracking drug-resistant malaria and tested the safely and efficacy of triple ACTs (TACTs) to treat multi-drug resistant falciparum malaria, which is a major and worsening threat to global malaria control and elimination efforts. DeTACT, a large follow-up project funded by DFID will expand the evaluation of TACTs to African countries and aims to have 2 different TACTs ready for deployment by the end of the project.